Former Tottenham Hotspur star, Dele Alli has reached an agreement to join Como. Alli has been training with the Serie A side for the past few weeks. The former Everton and Besiktas player was in ...

In his address, the Commissioner, Ministry of Basic and Secondary Education, Mr. Jamiu Tolani Alli-Balogun, stated that the initiative would get the learners and candidates energise one another to ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

Copyright 2025 The Associated Press. All Rights Reserved. In this image provided by the Macuga family, sisters, from left, Sam, Lauren and Alli Macuga pose in Park ...

The trio each make compelling cases. Alli, the moguls standout, touts the knee-jarring bumps and jumps; Lauren, the downhill ski racer, cites speeds in excess of 70 mph (112.6 kph) along an icy ...

GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare Conference, the European healthcare giant noted there ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

A new solar farm will provide electricity to a major manufacturer in County Durham. The new facility at Stainton, near Barnard Castle, will power the nearby Glaxo Smith Kline factory for 40 years.

Eli Lilly made a $2.5 billion deal for a breast cancer drug; GSK reached a $1 billion-plus deal for IDRx. The announcements suggest a potential rebound in M&A deals in the healthcare sector for 2025.

In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal cancer asset. “We really became impressed with what IDRx had achieved ...

January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...